Evidence map›Paper›PMID 20209642›Full record

ArticleThe Prostate2010

Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression.

JianFeng Zhang, Nan Gao, David J DeGraff, Xiuping Yu, Qian Sun, Thomas C Case, Susan Kasper, Robert J Matusik

Abstract read
In one paragraph

Article in The Prostate, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype.Laboratory investigation; a journal of technical methods and pathology · 2014
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

JianFeng ZhangDepartment of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee.
Nan Gao
David J DeGraff
Xiuping Yu
Qian Sun
Thomas C Case
Susan Kasper
Robert J Matusik
Vanderbilt University Medical Center · USUniversity of Cincinnati · US

Funding

Integrated Biological Systems Training in OncologyT32CA119925 · NCI · VANDERBILT UNIVERSITY · PI Vivian Gama, William Patrick Tansey · 2008 to 2026
$7.6M
TRANSGENIC MOUSE MODEL FOR PROSTATE CANCERR01CA076142 · NCI · VANDERBILT UNIVERSITY · PI MATUSIK, ROBERT J. · 1998 to 2012
$4.8M
CONTROL OF PROSTATE-SPECIFIC GENE EXPRESSIONR01DK055748 · NIDDK · VANDERBILT UNIVERSITY · PI MATUSIK, ROBERT J. · 1999 to 2013
$4.1M
Regulation of Apical-Basal Cell polarity during Intestinal Epithelial MorphogenesK01DK085194 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GAO, NAN · 2010 to 2014
$728k
NCI NIH HHS R01 CA076142NCI NIH HHS T32 CA119925NIDDK NIH HHS K01 DK085194NIDDK NIH HHS R01 DK055748NIDDK NIH HHS R01-DK055748
6 · The paper itself

Abstract

backgroundThe androgen-regulated probasin (PB) promoter has been used extensively to target transgenes to the prostate in transgenic mice; however, limited data exist on the mechanism that dictates prostate-specific gene expression. Tissue-specific gene expression involves synergistic effects among transcription factors associated in a complex bound to cis-acting DNA elements.

methodsUsing comprehensive linker scan mutagenesis, enzyme mobility shift and supershift assays, chromatin immunoprecipitation, and transgenic animal studies, we have extensively characterized the prostate-specific PB promoter.

resultsWe identified a series of nonreceptor transcription factors that are bound to the prostate-specific rat PB promoter. These factors include several ubiquitously distributed proteins known to participate in steroid receptor-mediated transcription. In addition, we identified two tissue-specific DNA elements that are crucial in directing prostate-specific PB expression, and confirmed the functional importance of both elements in transgenic animal studies. These two elements are functionally interchangeable and can be bound by multiple protein complexes, including the forkhead transcription factor FoxA1, a "pioneer factor" that has a restricted distribution to some cells type that are ectoderm and endoderm in origin. Using transgenic mice, we further demonstrate that the minimal PB promoter region (-244/-96 bp) that encompasses these tissue-specific elements results in prostate-specific gene expression in transgenic mice, contains androgen receptor and FoxA1-binding sites, as well as ubiquitous transcription factor binding sites.

conclusionWe propose that these sequence-specific DNA-binding proteins, including tissue-restricted and ubiquitous factors, create the first level of transcriptional control, which responds to intracellular pathways that directs prostate-specific gene expression.

Indexed as

Androgen-Binding ProteinAndrogensAnimalsBinding SitesCell Line, TumorCells, CulturedChromatin ImmunoprecipitationElectrophoretic Mobility Shift AssayGene Expression RegulationHumansMaleMiceMice, TransgenicPromoter Regions, GeneticProstateRatsAndrogen-Binding ProteinAndrogensprobasin

Identifiers

PMID20209642
PMCPMC3712623
OpenAlexW2049467928

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.